FEV1 AS A PROGNOSTIC FACTOR FOR SURVIVAL IN STAGE III NSCLC PATIENTS TREATED WITH CHEMORADIATION: MULTIVARIATE ANALYSIS OF CHERNOS TRIAL
Chest(2008)
摘要
PURPOSE: Data from the recent HOG 01–24 trial suggest that survival of stage III NSCLC patients (pts) treated with chemoradiotherapy (CRT) is correlated with the FEV1. In this multivariate analysis we evaluated the prognostic value of FEV1 and/or DLCO in pts treated with CRT in the Chernos trial.
更多查看译文
关键词
stage iii nsclc patients,chemoradiation,chernos trial,prognostic factor
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要